Citations (199)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Zhengdong Ai, Chong Ma, Ruiming Wan, Jingyi Yin, Guiming Li, Yan Li & Li Chen. (2022) Anticancer Activity and Molecular Mechanism of Momordica cochinchinensis Seed Extract in Chronic Myeloid Leukemia Cells. Nutrition and Cancer 74:7, pages 2644-2656.
Read now
Read now
Weidong Yu, Xiaolin Sun, Hongxing Tang, Yunxia Tao & Zonghan Dai. (2010) Inhibition of class II phosphoinositide 3-kinase γ expression by p185Bcr–Abl contributes to impaired chemotaxis and aberrant homing of leukemic cells. Leukemia & Lymphoma 51:6, pages 1098-1107.
Read now
Read now
Ryoko Kuribara, Hiroaki Honda, Hirotaka Matsui, Tetsuharu Shinjyo, Takeshi Inukai, Kanji Sugita, Shinpei Nakazawa, Hisamaru Hirai, Keiya Ozawa & Toshiya Inaba. (2004) Roles of Bim in Apoptosis of Normal and Bcr-Abl-Expressing Hematopoietic Progenitors. Molecular and Cellular Biology 24:14, pages 6172-6183.
Read now
Read now
Ryan P. Million, Nari Harakawa, Sergei Roumiantsev, Lyuba Varticovski & Richard A. Van Etten. (2004) A Direct Binding Site for Grb2 Contributes to Transformation and Leukemogenesis by the Tel-Abl (ETV6-Abl) Tyrosine Kinase. Molecular and Cellular Biology 24:11, pages 4685-4695.
Read now
Read now
Faris QB Alenzi, Richard KH Wyse & Waleed G Altamimi. (2004) Apoptosis as a tool for therapeutic agents in haematological diseases. Expert Opinion on Biological Therapy 4:3, pages 407-420.
Read now
Read now
Tetsuharu Shinjyo, Ryoko Kuribara, Takeshi Inukai, Hajime Hosoi, Taisei Kinoshita, Atsushi Miyajima, Peter J. Houghton, A. Thomas Look, Keiya Ozawa & Toshiya Inaba. (2001) Downregulation of Bim, a Proapoptotic Relative of Bcl-2, Is a Pivotal Step in Cytokine-Initiated Survival Signaling in Murine Hematopoietic Progenitors. Molecular and Cellular Biology 21:3, pages 854-864.
Read now
Read now
Xiaowu Zhang, Ramesh Subrahmanyam, Ray Wong, Alec W. Gross & Ruibao Ren. (2001) The NH2-Terminal Coiled-Coil Domain and Tyrosine 177 Play Important Roles in Induction of a Myeloproliferative Disease in Mice by Bcr-Abl. Molecular and Cellular Biology 21:3, pages 840-853.
Read now
Read now
M. Ahmed, I. Dusanter-Fourt, A. Dugray, L. Dubrez, S. Novault, M. L. Bonnet, S. Gisselbrecht, B. Varet, E. Solary, W. Vainchenker & A. G. Turhan. (2001) BCR-ABL Fails to Inhibit Apoptosis in U937 Myelomonocytic Cells Expressing a Carboxyl-Terminal Truncated Stat5. Leukemia & Lymphoma 42:3, pages 445-455.
Read now
Read now
Gary W. Reuther, Que T. Lambert, Michael A. Caligiuri & Channing J. Der. (2000) Identification and Characterization of an Activating TrkA Deletion Mutation in Acute Myeloid Leukemia. Molecular and Cellular Biology 20:23, pages 8655-8666.
Read now
Read now
Danilo Perrotti, Angela Iervolino, Vincenzo Cesi, Maria Cirinná, Silvia Lombardini, Emanuela Grassilli, Silvia Bonatti, Pier Paolo Claudio & Bruno Calabretta. (2000) BCR-ABL Prevents c-Jun-Mediated and Proteasome-Dependent FUS (TLS) Proteolysis through a Protein Kinase CβII-Dependent Pathway. Molecular and Cellular Biology 20:16, pages 6159-6169.
Read now
Read now
Mehran S. Neshat, Arthur B. Raitano, Hong-Gang Wang, John C. Reed & Charles L. Sawyers. (2000) The Survival Function of the Bcr-Abl Oncogene Is Mediated by Bad-Dependent and -Independent Pathways: Roles for Phosphatidylinositol 3-Kinase and Raf. Molecular and Cellular Biology 20:4, pages 1179-1186.
Read now
Read now
Alec W. Gross, Xiaowu Zhang & Ruibao Ren. (1999) Bcr-Abl with an SH3 Deletion Retains the Ability To Induce a Myeloproliferative Disease in Mice, yet c-Abl Activated by an SH3 Deletion Induces Only Lymphoid Malignancy. Molecular and Cellular Biology 19:10, pages 6918-6928.
Read now
Read now
Ryoko Kuribara, Taisei Kinoshita, Atsushi Miyajima, Tetsuharu Shinjyo, Takao Yoshihara, Takeshi Inukai, Keiya Ozawa, A. Thomas Look & Toshiya Inaba. (1999) Two Distinct Interleukin-3-Mediated Signal Pathways, Ras-NFIL3 (E4BP4) and Bcl-xL, Regulate the Survival of Murine Pro-B Lymphocytes. Molecular and Cellular Biology 19:4, pages 2754-2762.
Read now
Read now
Ren-Yuan Bai, Peter Dieter, Christian Peschel, Stephan W. Morris & Justus Duyster. (1998) Nucleophosmin-Anaplastic Lymphoma Kinase of Large-Cell Anaplastic Lymphoma Is a Constitutively Active Tyrosine Kinase That Utilizes Phospholipase C-γ To Mediate Its Mitogenicity. Molecular and Cellular Biology 18:12, pages 6951-6961.
Read now
Read now
Kenneth R. LaMontagne$suffix/text()$suffix/text(), Andrew J. Flint, B. Robert Franza$suffix/text()$suffix/text(), Ann Marie Pendergast & Nicholas K. Tonks. (1998) Protein Tyrosine Phosphatase 1B Antagonizes Signalling by Oncoprotein Tyrosine Kinase p210 bcr-abl In Vivo. Molecular and Cellular Biology 18:5, pages 2965-2975.
Read now
Read now
X. Y. D. Guo, Jason Font Ana, Donald Kufe & Albert Deisserpth. (1998) Antagonistic Effects of ABL and BCRABL Proteins on Proliferation and the Response to Genotoxic Stress in Normal and Leukemic Myeloid Cells. Leukemia & Lymphoma 30:3-4, pages 225-235.
Read now
Read now
Eva M. Weissinger, Günther Eissner, Christine Grammer, Susanne Fackler, Burkhard Haefner, Luke S. Yoon, Kimberly S. Lu, Alex Bazarov, John M. Sedivy, Harald Mischak & Walter Kolch. (1997) Inhibition of the Raf-1 Kinase by Cyclic AMP Agonists Causes Apoptosis of v-abl-Transformed Cells. Molecular and Cellular Biology 17:6, pages 3229-3241.
Read now
Read now
Articles from other publishers (182)
Gabriela Brumatti, Deeksha Kaloni, Fabíola Attié Castro & Gustavo P. Amarante-Mendes. (2023) BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia. Biochemical Journal 480:2, pages 161-176.
Crossref
Crossref
Gustavo P. Amarante-Mendes, Aamir Rana, Tarcila Santos Datoguia, Nelson Hamerschlak & Gabriela Brumatti. (2022) BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. Pharmaceutics 14:1, pages 215.
Crossref
Crossref
Joselle Cook & Mark Litzow. (2020) Advances in Supportive Care for Acute Lymphoblastic Leukemia. Current Hematologic Malignancy Reports 15:4, pages 276-293.
Crossref
Crossref
Mariusz Mojzych, Zofia Bernat, Zbigniew Karczmarzyk, Joanna Matysiak & Andrzej Fruziński. (2020) Synthesis, Structural Characterization, and Biological Activity of New Pyrazolo[4,3-e][1,2,4]triazine Acyclonucleosides. Molecules 25:1, pages 221.
Crossref
Crossref
Maro Ohanian, Ana Tari Ashizawa, Guillermo Garcia-Manero, Naveen Pemmaraju, Tapan Kadia, Elias Jabbour, Farhad Ravandi, Gautam Borthakur, Michael Andreeff, Marina Konopleva, Miranda Lim, Sherry Pierce, Susan O'Brien, Yesid Alvarado, Srdan Verstovsek, William Wierda, Hagop Kantarjian & Jorge Cortes. (2018) Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial. The Lancet Haematology 5:4, pages e136-e146.
Crossref
Crossref
Janaína Peixoto-da-Silva, Andrana K. Calgarotto, Katiucha R. Rocha, Caroline Palmeira-dos-Santos, Soraya S. Smaili, Gustavo J.S. Pereira, Fernando V. Pericole, Adriana da Silva S. Duarte, Sara T.O. Saad & Claudia Bincoletto. (2018) Lithium, a classic drug in psychiatry, improves nilotinib-mediated antileukemic effects. Biomedicine & Pharmacotherapy 99, pages 237-244.
Crossref
Crossref
V. Lavanya, Neesar Ahmed, Md Khurshid Alam Khan & Shazia Jamal. (2016) Sustained mitogenic effect on K562 human chronic myelogenous leukemia cells by dietary lectin, jacalin. Glycoconjugate Journal 33:6, pages 877-886.
Crossref
Crossref
Chengbin Yang, Nishtha Panwar, Yucheng Wang, Butian Zhang, Maixian Liu, Huiting Toh, Ho Sup Yoon, Swee Chuan Tjin, Peter Han Joo Chong, Wing-Cheung Law, Chih-Kuang Chen & Ken-Tye Yong. (2016) Biodegradable charged polyester-based vectors (BCPVs) as an efficient non-viral transfection nanoagent for gene knockdown of the BCR–ABL hybrid oncogene in a human chronic myeloid leukemia cell line. Nanoscale 8:17, pages 9405-9416.
Crossref
Crossref
Itaru Matsumura. 2016. Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia. Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
29
52
.
Giorgia Montano, Karina Vidovic, Chiara Palladino, Elena Cesaro, Gaetano Sodaro, Concetta Quintarelli, Biagio De Angelis, Santa Errichiello, Fabrizio Pane, Paola Izzo, Michela Grosso, Urban Gullberg & Paola Costanzo. (2015) WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene. Oncotarget 6:29, pages 28223-28237.
Crossref
Crossref
Sitapriya Moorthi & Chiara Luberto. 2015. Bioactive Sphingolipids in Cancer Biology and Therapy. Bioactive Sphingolipids in Cancer Biology and Therapy
53
79
.
DingBiao Zou, YaTao Qiu, ZhengChao Tu, ChenZhong Liao, JinFeng Luo, QingQing Meng, RiSheng Yao, Zheng Li & Sheng Jiang. (2013) Biological evaluation of 2-methylpyrimidine derivatives as active pan Bcr-Abl inhibitors. Science China Chemistry 57:6, pages 823-832.
Crossref
Crossref
Hao-Yuan Cheng & Fu-Hsiang Ko. (2014) Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia. Life Sciences 102:2, pages 118-126.
Crossref
Crossref
Christine Victoria Ichim. (2014) Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors. Stem Cells Translational Medicine 3:4, pages 405-415.
Crossref
Crossref
Anum Mughal, Hafiz Muhammad Aslam, Aga Muhammad Hammad Khan, Shafaq Saleem, Ribak Umah & Maria Saleem. (2013) Bcr-Abl tyrosine kinase inhibitors- current status. Infectious Agents and Cancer 8:1.
Crossref
Crossref
Jessica Fredericks & Ruibao Ren. (2013) The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia. Frontiers of Medicine 7:4, pages 452-461.
Crossref
Crossref
Anita Roy, Lakshmishri Lahiry, Debasis Banerjee, Malay Ghosh & Subrata Banerjee. (2013) Increased Cytoplasmic Localization of p27kip1 and Its Modulation of RhoA Activity during Progression of Chronic Myeloid Leukemia. PLoS ONE 8:10, pages e76527.
Crossref
Crossref
Wei Wei, He Huang, Shan Zhao, Wei Liu, Chuan-Xu Liu, Li Chen, Jun-Min Li, Ying-Li Wu & Hua Yan. (2013) Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion. Apoptosis 18:9, pages 1060-1070.
Crossref
Crossref
N. I. Grineva, T. V. Akhlynina, A. M. Timofeev, L. P. Gerasimova, D. A. Schmarov, N. M. Nydenova, T. E. Manakova, T. G. Sarycheva & L. G. Kovaleva. (2013) Apoptosis and neutrophils in the regulation of Ph-positive myeloid cell proliferation and differentiation ex vivo. Molecular Biology 47:4, pages 559-571.
Crossref
Crossref
Shamudheen Rafiyath, Guoqing Wei & Delong Liu. 2013. Handbook of Therapeutic Biomarkers in Cancer. Handbook of Therapeutic Biomarkers in Cancer
233
265
.
Mariana Flavia da Mota, Polyana Lopes Benfica & Marize Campos Valadares. (2012) Synadenium umbellatum Pax. promotes cell cycle arrest and induces apoptosis in K-562 leukemia cells. Brazilian Journal of Pharmaceutical Sciences 48:3, pages 497-505.
Crossref
Crossref
S. Nakamura, T. Takemura, L. Tan, Y. Nagata, D. Yokota, I. Hirano, K. Shigeno, K. Shibata, M. Fujie, S. Fujisawa & K. Ohnishi. (2011) Small GTPase RAB45-mediated p38 activation in apoptosis of chronic myeloid leukemia progenitor cells. Carcinogenesis 32:12, pages 1758-1772.
Crossref
Crossref
Zhongzheng Lu, Yanli Jin, Lin Qiu, Yingrong Lai & Jingxuan Pan. (2010) Celastrol, a novel HSP90 inhibitor, depletes Bcr–Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation. Cancer Letters 290:2, pages 182-191.
Crossref
Crossref
Kara J. Johnson, Ian J. Griswold, Thomas O'Hare, Amie S. Corbin, Marc Loriaux, Michael W. Deininger & Brian J. Druker. (2009) A BCR-ABL Mutant Lacking Direct Binding Sites for the GRB2, CBL and CRKL Adapter Proteins Fails to Induce Leukemia in Mice. PLoS ONE 4:10, pages e7439.
Crossref
Crossref
Yan-Lin Wei, Yun Liang, Lei Xu & Xiao-Ying Zhao. (2009) The Antiproliferation Effect of Berbamine on K562 Resistant Cells by Inhibiting NF-κB Pathway. The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 292:7, pages 945-950.
Crossref
Crossref
Cristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton, G. Vignir Helgason, Angela Rachele Soliera, Mattia Ronchetti, Sara Galavotti, Kenneth W. Young, Tommaso Selmi, Rinat Yacobi, Richard A. Van Etten, Nick Donato, Ann Hunter, David Dinsdale, Elena Tirrò, Paolo Vigneri, Pierluigi Nicotera, Martin J. Dyer, Tessa Holyoake, Paolo Salomoni & Bruno Calabretta. (2009) Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells. Journal of Clinical Investigation 119:5, pages 1109-1123.
Crossref
Crossref
C H M Jamieson, C F Barroga & W P Vainchenker. (2008) Miscreant myeloproliferative disorder stem cells. Leukemia 22:11, pages 2011-2019.
Crossref
Crossref
Margret S. RodriguesMamatha M. ReddyMartin Sattler. (2008) Cell Cycle Regulation by Oncogenic Tyrosine Kinases in Myeloid Neoplasias: From Molecular Redox Mechanisms to Health Implications. Antioxidants & Redox Signaling 10:10, pages 1813-1848.
Crossref
Crossref
Edward Kavalerchik, Daniel Goff & Catriona H.M. Jamieson. (2008) Chronic Myeloid Leukemia Stem Cells. Journal of Clinical Oncology 26:17, pages 2911-2915.
Crossref
Crossref
Catriona H. Jamieson. (2008) Chronic Myeloid Leukemia Stem Cells. Hematology 2008:1, pages 436-442.
Crossref
Crossref
Zainab Jagani, Amrik Singh & Roya Khosravi-Far. (2008) FoxO tumor suppressors and BCR–ABL-induced leukemia: A matter of evasion of apoptosis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1785:1, pages 63-84.
Crossref
Crossref
Fabrizia Brisdelli, Cristina Coccia, Benedetta Cinque, Maria Grazia Cifone & Argante Bozzi. (2006) Induction of apoptosis by quercetin: different response of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells. Molecular and Cellular Biochemistry 296:1-2, pages 137-149.
Crossref
Crossref
Ricardo H. Alvarez, Hagop Kantarjian & Jorge E. Cortes. (2007) The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy. Seminars in Hematology 44, pages 4-14.
Crossref
Crossref
Michael W. N. Deininger. 2007. Myeloproliferative Disorders. Myeloproliferative Disorders
75
102
.
Hetal Patel, Stephen B. Marley & Myrtle Y. Gordon. (2006) Detection in primary chronic myeloid leukaemia cells of p210BCR-ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2. Genes, Chromosomes and Cancer 45:12, pages 1121-1129.
Crossref
Crossref
Guangsen Zhang & Yunbi Fu. (2006) Antiproliferative effect of indomethacin on CML cells is related to the suppression of STATs/Bcl-XL signal pathway. Annals of Hematology 85:7, pages 443-449.
Crossref
Crossref
S D Turner & D R Alexander. (2006) Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells. Leukemia 20:4, pages 572-582.
Crossref
Crossref
Guang-Sen Zhang, Ding-Sheng Liu, Chong-Wen Dai & Rui-Juan Li. (2006) Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. American Journal of Hematology 81:4, pages 242-255.
Crossref
Crossref
Mario NotariPaolo NevianiRamasamy SanthanamBradley W. BlaserJi-Suk ChangAnnamaria GaliettaAnne E. WillisDenis C. RoyMichael A. CaligiuriGuido MarcucciDanilo Perrotti. (2006) A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood 107:6, pages 2507-2516.
Crossref
Crossref
N. Underhill-Day, A. Pierce, S. E. Thompson, D. Xenaki, A. D. Whetton & P. J. Owen-Lynch. (2006) Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. British Journal of Haematology 132:6, pages 774-783.
Crossref
Crossref
Christoph Walz & Martin Sattler. (2006) Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML). Critical Reviews in Oncology/Hematology 57:2, pages 145-164.
Crossref
Crossref
Jungeun Park, Sangmi Kim, Chongkil Oh, Sung Soo Yoon, Dongsoon Lee & Youngsoo Kim. (2005) Differential tyrosine phosphorylation of leukemic cells during apoptosis as a result of treatment with imatinib mesylate. Biochemical and Biophysical Research Communications 336:3, pages 942-951.
Crossref
Crossref
A.R. Lizzi, A.M. D’Alessandro, N. Zeolla, F. Brisdelli, G. D’Andrea, G. Pitari, A. Oratore, A. Bozzi & R. Ippoliti. (2005) The effect of AZT and chloroquine on the activities of ricin and a saporin–transferrin chimeric toxin. Biochemical Pharmacology 70:4, pages 560-569.
Crossref
Crossref
Stephen B. MARLEYMyrtle Y. GORDON. (2005) Chronic myeloid leukaemia: stem cell derived but progenitor cell driven. Clinical Science 109:1, pages 13-25.
Crossref
Crossref
M Jongen-Lavrencic, S Salesse, R Delwel & C M Verfaillie. (2005) BCR/ABL-mediated downregulation of genes implicated in cell adhesion and motility leads to impaired migration toward CCR7 ligands CCL19 and CCL21 in primary BCR/ABL-positive cells. Leukemia 19:3, pages 373-380.
Crossref
Crossref
Linda B. Baughn & Naomi Rosenberg. (2005) Disruption of the Shc/Grb2 Complex during Abelson Virus Transformation Affects Proliferation, but Not Apoptosis. Journal of Virology 79:4, pages 2325-2334.
Crossref
Crossref
E Deutsch, L Maggiorella, B Wen, M L Bonnet, K Khanfir, V Frascogna, A G Turhan & J Bourhis. (2004) Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation. British Journal of Cancer 91:9, pages 1735-1741.
Crossref
Crossref
Sutapa Ray, Ying Lu, Scott H. Kaufmann, W. Clay Gustafson, Judith E. Karp, Istvan Boldogh, Alan P. Fields & Allan R. Brasier. (2004) Genomic Mechanisms of p210BCR-ABL Signaling. Journal of Biological Chemistry 279:34, pages 35604-35615.
Crossref
Crossref
Natasa Kukoc-Zivojnov, Elena Puccetti, Kai U Chow, Marion Bergmann, Martin Ruthardt, Dieter Hoelzer, Paris S Mitrou, Eckhart Weidmann & Simone Boehrer. (2004) Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185BCR-ABL in hematopoietic cells. Experimental Hematology 32:7, pages 649-656.
Crossref
Crossref
Bruno CalabrettaDanilo Perrotti. (2004) The biology of CML blast crisis. Blood 103:11, pages 4010-4022.
Crossref
Crossref
Anjali S Advani. (2004) Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia. Leukemia Research 28:6, pages 545-546.
Crossref
Crossref
Robert L IlariaJrJr. (2004) Animal models of chronic myelogenous leukemia. Hematology/Oncology Clinics of North America 18:3, pages 525-543.
Crossref
Crossref
Richard A Van Etten. (2004) Mechanisms of transformation by the BCR-ABL oncogene: new perspectives in the post-imatinib era. Leukemia Research 28, pages 21-28.
Crossref
Crossref
Danilo Perrotti & Bruno Calabretta. (2004) Translational regulation by the p210 BCR/ABL oncoprotein. Oncogene 23:18, pages 3222-3229.
Crossref
Crossref
Stephane WongOwen N. Witte. (2004) The BCR-ABL Story: Bench to Bedside and Back. Annual Review of Immunology 22:1, pages 247-306.
Crossref
Crossref
W. Clay Gustafson, Sutapa Ray, Lee Jamieson, E. Aubrey Thompson, Allan R. Brasier & Alan P. Fields. (2004) Bcr-Abl Regulates Protein Kinase Cι (PKCι) Transcription via an Elk1 Site in the PKCι Promoter. Journal of Biological Chemistry 279:10, pages 9400-9408.
Crossref
Crossref
P Håkansson, C Lassen, T Olofsson, B Baldetorp, A Karlsson, U Gullberg & T Fioretos. (2004) Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a). Leukemia 18:3, pages 538-547.
Crossref
Crossref
Li Gong, Indira Unnikrishnan, Anuradha Raghavan, Kalindi Parmar & Naomi Rosenberg. (2004) Active Akt and Functional p53 Modulate Apoptosis in Abelson Virus-Transformed Pre-B Cells. Journal of Virology 78:4, pages 1636-1644.
Crossref
Crossref
Dia Xenaki, Andrew Pierce, Nick Underhill-Day, Anthony D. Whetton & P.Jane Owen-Lynch. (2004) Bcr-Abl-mediated molecular mechanism for apoptotic suppression in multipotent haemopoietic cells: a role for PKCβII. Cellular Signalling 16:2, pages 145-156.
Crossref
Crossref
Isabelle Gaston, Kara J Johnson, Tsukasa Oda, Arun Bhat, Margaret Reis, Wallace Langdon, Lei Shen, Michael W Deininger & Brian J Druker. (2004) Coexistence of phosphotyrosine-dependent and -independent interactions between Cbl and Bcr-Abl. Experimental Hematology 32:1, pages 113-121.
Crossref
Crossref
Daniela M Dinulescu, Lisa J Wood, Lei Shen, Marc Loriaux, Christopher L Corless, Alec W Gross, Ruibao Ren, Michael W N Deininger & Brian J Druker. (2003) c-CBL is not required for leukemia induction by Bcr-Abl in mice. Oncogene 22:55, pages 8852-8860.
Crossref
Crossref
Suparna Mishra, Anja Reichert, Jess Cunnick, Dinithi Senadheera, Bianca Hemmeryckx, Nora Heisterkamp & John Groffen. (2003) Protein kinase CKIIα interacts with the Bcr moiety of Bcr/Abl and mediates proliferation of Bcr/Abl-expressing cells. Oncogene 22:51, pages 8255-8262.
Crossref
Crossref
K Punareewattana, L.V Sharova, W Li, D.L Ward & S.D Holladay. (2003) Reduced birth defects caused by maternal immune stimulation may involve increased expression of growth promoting genes and cytokine GM-CSF in the spleen of diabetic ICR mice. International Immunopharmacology 3:12, pages 1639-1655.
Crossref
Crossref
Ryouhei Nawata, Toshiaki Yujiri, Yukinori Nakamura, Koichi Ariyoshi, Toru Takahashi, Yutaka Sato, Yoshitomo Oka & Yukio Tanizawa. (2003) MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-κB activation. Oncogene 22:49, pages 7774-7780.
Crossref
Crossref
Scott H Kaufmann & David L Vaux. (2003) Alterations in the apoptotic machinery and their potential role in anticancer drug resistance. Oncogene 22:47, pages 7414-7430.
Crossref
Crossref
Julie L. Hanson, Vasiliki Anest, Julie Reuther-Madrid & Albert S. Baldwin. (2003) Oncoprotein Suppression of Tumor Necrosis Factor-induced NFκB Activation Is Independent of Raf-controlled Pathways. Journal of Biological Chemistry 278:37, pages 34910-34917.
Crossref
Crossref
C Miething, C Mugler, R Grundler, J Hoepfl, R-Y Bai, C Peschel & J Duyster. (2003) Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo. Leukemia 17:9, pages 1695-1699.
Crossref
Crossref
Faris Q. B. Alenzi & Anthony N. Warrens. (2003) Cellular and molecular themes in apoptosis. Wiener Klinische Wochenschrift 115:15-16, pages 563-574.
Crossref
Crossref
Christian Sillaber, Matthias Mayerhofer, Hermine Agis, Verena Sagaster, Christine Mannhalter, Wolfgang R. Sperr, Klaus Geissler & Peter Valent. (2003) Chronic myeloid leukemia: Pathophysiology, diagnostic parameters, and current treatment conceptsChronische myeloische Leukämie: Pathophysiologie, Diagnostik und aktuelle Therapiekonzepte. Wiener Klinische Wochenschrift 115:13-14, pages 485-504.
Crossref
Crossref
Wenwen Chien, Nicola Tidow, Elizabeth A. Williamson, Lee-Yung Shih, Utz Krug, Arminja Kettenbach, Anthony C. Fermin, Chaim M. Roifman & H.Phillip Koeffler. (2003) Characterization of a Myeloid Tyrosine Phosphatase, Lyp, and Its Role in the Bcr-Abl Signal Transduction Pathway. Journal of Biological Chemistry 278:30, pages 27413-27420.
Crossref
Crossref
B Clarkson, A Strife, D Wisniewski, C L Lambek & C Liu. (2003) Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies. Leukemia 17:7, pages 1211-1262.
Crossref
Crossref
Elena G. ChioreanScott J. DyllaKrista OlsenTodd LenvikYvette SoignierJeffrey S. Miller. (2003) BCR/ABL alters the function of NK cells and the acquisition of killer immunoglobulin-like receptors (KIRs). Blood 101:9, pages 3527-3533.
Crossref
Crossref
A E B Bueno-da-Silva, G Brumatti, F O Russo, D R Green & G P Amarante-Mendes. (2003) Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity. Cell Death & Differentiation 10:5, pages 592-598.
Crossref
Crossref
Martin Sattlermc & James D. Griffin. (2003) Molecular mechanisms of transformation by the BCR-ABL oncogene. Seminars in Hematology 40, pages 4-10.
Crossref
Crossref
Fabrizia Brisdelli, Egidio Iorio, Arno Knijn, Amalia Ferretti, Donatella Marcheggiani, Luisa Lenti, Roberto Strom, Franca Podo & Argante Bozzi. (2003) Two-step formation of 1H NMR visible mobile lipids during apoptosis of paclitaxel-treated K562 cells. Biochemical Pharmacology 65:8, pages 1271-1280.
Crossref
Crossref
Rossana Trotta, Tatiana Vignudelli, Olivia Candini, Robert V. Intine, Luisa Pecorari, Clara Guerzoni, Giorgia Santilli, Mike W. Byrom, Silvia Goldoni, Lance P. Ford, Michael A. Caligiuri, Richard J. Maraia, Danilo Perrotti & Bruno Calabretta. (2003) BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell 3:2, pages 145-160.
Crossref
Crossref
Fabı́ola Traina, José Barreto C Carvalheira, Mario J.A Saad, Fernando F Costa & Sara T.O Saad. (2003) BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells. FEBS Letters 535:1-3, pages 17-22.
Crossref
Crossref
Ruibao Ren. (2002) The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model. Oncogene 21:56, pages 8629-8642.
Crossref
Crossref
Jason A Wertheim, Juli P Miller, Lanwei Xu, Yiping He & Warren S Pear. (2002) The biology of chronic myelogenous leukemia:mouse models and cell adhesion. Oncogene 21:56, pages 8612-8628.
Crossref
Crossref
Ramadevi Nimmanapalli & Kapil Bhalla. (2002) Novel targeted therapies for Bcr–Abl positive acute leukemias: beyond STI571. Oncogene 21:56, pages 8584-8590.
Crossref
Crossref
Danilo Perrotti & Bruno Calabretta. (2002) Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene 21:56, pages 8577-8583.
Crossref
Crossref
Stephanie Salesse & Catherine M Verfaillie. (2002) BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia. Oncogene 21:56, pages 8547-8559.
Crossref
Crossref
Gary W. Reuther, Que T. Lambert, John F. Rebhun, Michael A. Caligiuri, Lawrence A. Quilliam & Channing J. Der. (2002) RasGRP4 Is a Novel Ras Activator Isolated from Acute Myeloid Leukemia. Journal of Biological Chemistry 277:34, pages 30508-30514.
Crossref
Crossref
AS Shet, BN Jahagirdar & CM Verfaillie. (2002) Chronic myelogenous leukemia: mechanisms underlying disease progression. Leukemia 16:8, pages 1402-1411.
Crossref
Crossref
Anjali S. Advani & Ann Marie Pendergast. (2002) Bcr–Abl variants: biological and clinical aspects. Leukemia Research 26:8, pages 713-720.
Crossref
Crossref
Martin Sattler, M.Golam Mohi, Yuri B Pride, Laura R Quinnan, Nicole A Malouf, Klaus Podar, Franck Gesbert, Hiromi Iwasaki, Shaoguang Li, Richard A Van Etten, Haihua Gu, James D Griffin & Benjamin G Neel. (2002) Critical role for Gab2 in transformation by BCR/ABL. Cancer Cell 1:5, pages 479-492.
Crossref
Crossref
Carlo B. Gambacorti-Passerini, Francesca Rossi, Magda Verga, Holger Ruchatz, Rosalind Gunby, Roberta Frapolli, Massimo Zucchetti, Leonardo Scapozza, Silvia Bungaro, Lucia Tornaghi, Fabio Rossi, Pietro Pioltelli, Enrico Pogliani, Maurizio D'Incalci & Gianmarco Corneo. (2002) Differences between in Vivo and in Vitro Sensitivity to Imatinib of Bcr/Abl+ Cells Obtained from Leukemic Patients. Blood Cells, Molecules, and Diseases 28:3, pages 361-372.
Crossref
Crossref
Yiping HeJason A. WertheimLanwei XuJuli P. MillerFredrick G. KarnellJohn K. ChoiRuibao RenWarren S. Pear. (2002) The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia–like disease by bcr/abl. Blood 99:8, pages 2957-2968.
Crossref
Crossref
Florian Bassermann, Thomas Jahn, Cornelius Miething, Petra Seipel, Ren-Yuan Bai, Sunita Coutinho, Christian Peschel, Justus Duyster & Victor L. Tybulewicz. (2002) Association of Bcr-Abl with the Proto-oncogene Vav Is Implicated in Activation of the Rac-1 Pathway. Journal of Biological Chemistry 277:14, pages 12437-12445.
Crossref
Crossref
David G. Savage & Karen H. Antman. (2002) Imatinib Mesylate — A New Oral Targeted Therapy. New England Journal of Medicine 346:9, pages 683-693.
Crossref
Crossref
Jay F. DorseyJess M. CunnickShrikant M. ManeJie Wu. (2002) Regulation of the Erk2-Elk1 signaling pathway and megakaryocytic differentiation of Bcr-Abl+ K562 leukemic cells by Gab2. Blood 99:4, pages 1388-1397.
Crossref
Crossref
SS Clark, SM Perman, MB Sahin, GJ Jenkins & JA Elegbede. (2002) Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest. Leukemia 16:2, pages 213-222.
Crossref
Crossref
Bruno Calabretta. 2002. Wiley Encyclopedia of Molecular Medicine. Wiley Encyclopedia of Molecular Medicine.
Aaron D. SchimmerDavid W. HedleyLinda Z. PennMark D. Minden. (2001) Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood 98:13, pages 3541-3553.
Crossref
Crossref
K Keeshan, KI Mills, TG Cotter & SL McKenna. (2001) Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype. Leukemia 15:12, pages 1823-1833.
Crossref
Crossref
Saghi GhaffariClaire KitidisMark D. FlemingHans NeubauerKlaus PfefferHarvey F. Lodish. (2001) Erythropoiesis in the absence of janus-kinase 2: BCR-ABL induces red cell formation in JAK2−/− hematopoietic progenitors. Blood 98:10, pages 2948-2957.
Crossref
Crossref
Vasily M. GelfanovGem S. BurgessSara Litz-JacksonAlastair J. KingMark S. MarshallHarikrishna NakshatriH. Scott Boswell. (2001) Transformation of interleukin-3–dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor κB–mediated antiapoptosis involving c-IAP2. Blood 98:8, pages 2508-2517.
Crossref
Crossref
Christian KardinalBirgit KonkolHui LinManfred EulitzEnrico K. SchmidtZeev EstrovMoshe TalpazRalph B. ArlinghausStephan M. Feller. (2001) Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SoS complexes. Blood 98:6, pages 1773-1781.
Crossref
Crossref
Stephane Wong & Owen N Witte. (2001) Modeling Philadelphia chromosome positive leukemias. Oncogene 20:40, pages 5644-5659.
Crossref
Crossref
Heiko van der KuipAlexander W. GoetzCornelius MiethingJustus DuysterWalter E. Aulitzky. (2001) Adhesion to fibronectin selectively protects Bcr-Abl+cells from DNA damage–induced apoptosis. Blood 98:5, pages 1532-1541.
Crossref
Crossref
B Bruecher-Encke, JD Griffin, BG Neel & U Lorenz. (2001) Role of the tyrosine phosphatase SHP-1 in K562 cell differentiation. Leukemia 15:9, pages 1424-1432.
Crossref
Crossref
Ying Lu, Lee Jamieson, Allan R Brasier & Alan P Fields. (2001) NF-κB/RelA transactivation is required for atypical protein kinase Cι-mediated cell survival. Oncogene 20:35, pages 4777-4792.
Crossref
Crossref
John P. Perentesis & Eric L. Sievers. (2001) Targeted Therapies for High-Risk Acute Myeloid Leukemia. Hematology/Oncology Clinics of North America 15:4, pages 677-701.
Crossref
Crossref
Carmen Rivas, Angela R.-M Miller, Manuel Collado, Eric W.-F Lam, Jane F Apperley & Junia V Melo. (2001) BCR-ABL-Expressing Cells Transduced with the HSV-tk Gene Die by Apoptosis upon Treatment with Ganciclovir. Molecular Therapy 3:5, pages 642-652.
Crossref
Crossref
Dr Tessa L. Holyoake. (2001) Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory. British Journal of Haematology 113:1, pages 11-23.
Crossref
Crossref
Martin Sattler & James D. Griffin. (2001) Mechanisms of Transformation by the BCR/ABL Oncogene. International Journal of Hematology 73:3, pages 278-291.
Crossref
Crossref
Katharina Pachmann, Shourong Zhao, Thomas Schenk, Hagop Kantarjian, Adel K. El-Naggar, Michael J. Siciliano, Jie-Qiang Guo, Ralph B. Arlinghaus & Michael Andreeff. (2001)
Expression of bcr-abl mRNA in individual chronic myelogenous leukaemia cells as determined by
in situ
amplification
. British Journal of Haematology 112:3, pages 749-759.
Crossref
Crossref
D Ferrero, C Foli, F Giaretta, C Argentino, C Rus & A Pileri. (2001) Growth advantage of chronic myeloid leukemia CFU-GM in vitro : survival to growth factor deprivation, possibly related to autocrine stimulation, is a more common feature than hypersensitivity to GM-CSF/IL3 and is efficiently counteracted by retinoids ± α-interferon. Leukemia 15:3, pages 422-429.
Crossref
Crossref
Celine A. Mainville, Kalindi Parmar, Indira Unnikrishnan, Li Gong, Glen D. Raffel & Naomi Rosenberg. (2001) Temperature-Sensitive Transformation by an Abelson Virus Mutant Encoding an Altered SH2 Domain. Journal of Virology 75:4, pages 1816-1823.
Crossref
Crossref
Paolo Vigneri & Jean Y. J. Wang. (2001) Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR–ABL tyrosine kinase. Nature Medicine 7:2, pages 228-234.
Crossref
Crossref
Xiaowu ZhangRay WongSheryl X. HaoWarren S. PearRuibao Ren. (2001) The SH2 domain of Bcr-Abl is not required to induce a murine myeloproliferative disease; however, SH2 signaling influences disease latency and phenotype. Blood 97:1, pages 277-287.
Crossref
Crossref
Ch. W. M. Reuter, M. A. Morgan & L. Bergmann. 2001. Acute Leukemias VIII. Acute Leukemias VIII
100
108
.
Maria CirinnàRossana TrottaPaolo SalomoniPlamen KossevMariusz WasikDanilo PerrottiBruno Calabretta. (2000) Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation. Blood 96:12, pages 3915-3921.
Crossref
Crossref
Maria CirinnàRossana TrottaPaolo SalomoniPlamen KossevMariusz WasikDanilo PerrottiBruno Calabretta. (2000) Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation. Blood 96:12, pages 3915-3921.
Crossref
Crossref
Michael W. N. DeiningerJohn M. GoldmanJunia V. Melo. (2000) The molecular biology of chronic myeloid leukemia. Blood 96:10, pages 3343-3356.
Crossref
Crossref
Michael W. N. DeiningerJohn M. GoldmanJunia V. Melo. (2000) The molecular biology of chronic myeloid leukemia. Blood 96:10, pages 3343-3356.
Crossref
Crossref
Alessandra Di Bacco, Karen Keeshan, Sharon L. McKenna & Thomas G. Cotter. (2000) Molecular Abnormalities in Chronic Myeloid Leukemia: Deregulation of Cell Growth and Apoptosis. The Oncologist 5:5, pages 405-415.
Crossref
Crossref
M Nieborowska-Skorska, A Slupianek & T Skorski. (2000) Progressive changes in the leukemogenic signaling in BCR/ABL-transformed cells. Oncogene 19:36, pages 4117-4124.
Crossref
Crossref
Paolo SalomoniFabrizio CondorelliShawn M. SweeneyBruno Calabretta. (2000) Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects. Blood 96:2, pages 676-684.
Crossref
Crossref
Paolo SalomoniFabrizio CondorelliShawn M. SweeneyBruno Calabretta. (2000) Versatility of BCR/ABL-expressing leukemic cells in circumventing proapoptotic BAD effects. Blood 96:2, pages 676-684.
Crossref
Crossref
Ryan P. MillionRichard A. Van Etten. (2000) The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood 96:2, pages 664-670.
Crossref
Crossref
Ryan P. MillionRichard A. Van Etten. (2000) The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase. Blood 96:2, pages 664-670.
Crossref
Crossref
Miriam Fogli, Carmelo Carlo-Stella, Antonio Curti, Marina Ratta, PierLuigi Tazzari, Ester Ragazzi, Simona Colla, Alessandra M Santucci, Sante Tura & Roberto M Lemoli. (2000) Transforming growth factor β3 inhibits chronic myelogenous leukemia hematopoiesis by inducing Fas-independent apoptosis. Experimental Hematology 28:7, pages 775-783.
Crossref
Crossref
Robert C. QuackenbushGary W. ReutherJuli P. MillerKevin D. CourtneyWarren S. PearAnn Marie Pendergast. (2000) Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases. Blood 95:9, pages 2913-2921.
Crossref
Crossref
SK Jain, I de Aos, Y Inai, F Liu & L Varticovski. (2000) Inactivation of wild-type BCR/ABL tyrosine kinase in hematopoietic cells by mild hyperthermia. Leukemia 14:5, pages 845-852.
Crossref
Crossref
Hagop Kantarjian, Junia V. Melo, Sante Tura, Sergio Giralt & Moshe Talpaz. (2000) Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies. Hematology 2000:1, pages 90-109.
Crossref
Crossref
Hagop Kantarjian, Junia V. Melo, Sante Tura, Sergio Giralt & Moshe Talpaz. (2000) Chronic Myelogenous Leukemia: Disease Biology and Current and Future Therapeutic Strategies. Hematology 2000:1, pages 90-109.
Crossref
Crossref
R Chopra, Q.Q Pu & A.G Elefanty. (1999) Biology of BCR-ABL. Blood Reviews 13:4, pages 211-229.
Crossref
Crossref
Saghi Ghaffari, Hong Wu, Melissa Gerlach, Ying Han, Harvey F. Lodish & George Q. Daley. (1999) BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells. Proceedings of the National Academy of Sciences 96:23, pages 13186-13190.
Crossref
Crossref
Stefan Faderl, Moshe Talpaz, Zeev Estrov, Susan O'Brien, Razelle Kurzrock & Hagop M. Kantarjian. (1999) The Biology of Chronic Myeloid Leukemia. New England Journal of Medicine 341:3, pages 164-172.
Crossref
Crossref
Kristi L Peters & Thomas E Smithgall. (1999) Tyrosine Phosphorylation Enhances the SH2 Domain-Binding Activity of Bcr and Inhibits Bcr Interaction with 14-3-3 Proteins. Cellular Signalling 11:7, pages 507-514.
Crossref
Crossref
Malgorzata Nieborowska-Skorska, Mariusz A. Wasik, Artur Slupianek, Paolo Salomoni, Toshio Kitamura, Bruno Calabretta & Tomasz Skorski. (1999) Signal Transducer and Activator of Transcription (STAT)5 Activation by BCR/ABL Is Dependent on Intact Src Homology (SH)3 and SH2 Domains of BCR/ABL and Is Required for Leukemogenesis. Journal of Experimental Medicine 189:8, pages 1229-1242.
Crossref
Crossref
Lee Jamieson, Lee Carpenter, Trevor J. Biden & Alan P. Fields. (1999) Protein Kinase Cι Activity Is Necessary for Bcr-Abl-mediated Resistance to Drug-induced Apoptosis. Journal of Biological Chemistry 274:7, pages 3927-3930.
Crossref
Crossref
N Cambier, Y Zhang, G Vairo, K Kosmopoulos, D Metcalf, N A Nicola & A G Elefanty. (1999) Expression of BCR – ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation. Oncogene 18:2, pages 343-352.
Crossref
Crossref
Joanna Gora-Tybor, Michael W. M. Deininger, John M. Goldman & Junia V. Melo. (1998) The susceptibility of Philadelphia chromosome positive cells to FAS-mediated apoptosis is not linked to the tyrosine kinase activity of BCR-ABL. British Journal of Haematology 103:3, pages 716-720.
Crossref
Crossref
Warren S. PearJuli P. MillerLanwei XuJohn C. PuiBenny SofferRobert C. QuackenbushAnn Marie PendergastRoderick BronsonJon C. AsterMartin L. ScottDavid Baltimore. (1998) Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow. Blood 92:10, pages 3780-3792.
Crossref
Crossref
Warren S. PearJuli P. MillerLanwei XuJohn C. PuiBenny SofferRobert C. QuackenbushAnn Marie PendergastRoderick BronsonJon C. AsterMartin L. ScottDavid Baltimore. (1998) Efficient and Rapid Induction of a Chronic Myelogenous Leukemia-Like Myeloproliferative Disease in Mice Receiving P210 bcr/abl-Transduced Bone Marrow. Blood 92:10, pages 3780-3792.
Crossref
Crossref
Tomasz Skorski, Pawel Wlodarski, Laurence Daheron, Paolo Salomoni, Malgorzata Nieborowska-Skorska, Miroslaw Majewski, Mariusz Wasik & Bruno Calabretta. (1998) BCR/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac. Proceedings of the National Academy of Sciences 95:20, pages 11858-11862.
Crossref
Crossref
Carmine SelleriJaroslaw P. MaciejewskiFabrizio PaneLuigia LucianoAnna Maria RaiolaIlaria MostardaFrancesco SalvatoreBruno Rotoli. (1998) Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis. Blood 92:3, pages 981-989.
Crossref
Crossref
Carmine SelleriJaroslaw P. MaciejewskiFabrizio PaneLuigia LucianoAnna Maria RaiolaIlaria MostardaFrancesco SalvatoreBruno Rotoli. (1998) Fas-Mediated Modulation of Bcr/Abl in Chronic Myelogenous Leukemia Results in Differential Effects on Apoptosis. Blood 92:3, pages 981-989.
Crossref
Crossref
JÜrgen R. Hannemann, Deborah M. Mcmanus, Janusz H. S. Kabarowski & Leanne M. Wiedemann. (1998)
Haemopoietic transformation by the
TEL/ABL
oncogene
. British Journal of Haematology 102:2, pages 475-485.
Crossref
Crossref
Erica K Evans & Sally Kornbluth. (1998) Regulation of apoptosis in Xenopus egg extracts. Advances in Enzyme Regulation 38:1, pages 265-280.
Crossref
Crossref
Paolo Salomoni, Mariusz A. Wasik, Richard F. Riedel, Krzysztof Reiss, John K. Choi, Tomasz Skorski & Bruno Calabretta. (1998) Expression of Constitutively Active Raf-1 in the Mitochondria Restores Antiapoptotic and Leukemogenic Potential of a Transformation-deficient BCR/ABL Mutant. Journal of Experimental Medicine 187:12, pages 1995-2007.
Crossref
Crossref
Zonghan Dai, Robert C. Quackenbush, Kevin D. Courtney, Matthew Grove, David Cortez, Gary W. Reuther & Ann Marie Pendergast. (1998) Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes & Development 12:10, pages 1415-1424.
Crossref
Crossref
Tarja Jonuleit, Christian Peschel, Renate Schwab, Heiko van der Kuip, Elisabeth Buchdunger, Thomas Fischer, Christoph Huber & Walter E. Aulitzky. (1998) Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factors. British Journal of Haematology 100:2, pages 295-303.
Crossref
Crossref
Byrne & Marshall. (1998) THE MOLECULAR PATHOPHYSIOLOGY OF MYELOID LEUKAEMIAS: Ras REVISITED. British Journal of Haematology 100:2, pages 256-264.
Crossref
Crossref
Catherine M. Verfaillie. (1998) BIOLOGY OF CHRONIC MYELOGENOUS LEUKEMIA. Hematology/Oncology Clinics of North America 12:1, pages 1-29.
Crossref
Crossref
Roman Herrera, Susan Hubbell, Stuart Decker & Lilli Petruzzelli. (1998) A Role for the MEK/MAPK Pathway in PMA-Induced Cell Cycle Arrest: Modulation of Megakaryocytic Differentiation of K562 Cells. Experimental Cell Research 238:2, pages 407-414.
Crossref
Crossref
Kohsuke Yanagisawa, Hayato Yamauchi, Masahiko Kaneko, Hidehisa Kohno, Hitoshi Hasegawa & Shigeru Fujita. (1998) Suppression of Cell Proliferation and the Expression of abcr-abl Fusion Gene and Apoptotic Cell Death in a New Human Chronic Myelogenous Leukemia Cell Line, KT-1, by Interferon-α. Blood 91:2, pages 641-648.
Crossref
Crossref
Kohsuke Yanagisawa, Hayato Yamauchi, Masahiko Kaneko, Hidehisa Kohno, Hitoshi Hasegawa & Shigeru Fujita. (1998) Suppression of Cell Proliferation and the Expression of abcr-abl Fusion Gene and Apoptotic Cell Death in a New Human Chronic Myelogenous Leukemia Cell Line, KT-1, by Interferon-α. Blood 91:2, pages 641-648.
Crossref
Crossref
Tomasz SkorskiMalgorzata Nieborowska-SkorskaPawel WlodarskiMariusz WasikRossana TrottaPalanisamy KanakarajPaolo SalomoniMark AntonyakRobert MartinezMiroslaw MajewskiAlbert WongBice PerussiaBruno Calabretta. (1998) The SH3 Domain Contributes to BCR/ABL-Dependent Leukemogenesis In Vivo: Role in Adhesion, Invasion, and Homing. Blood 91:2, pages 406-418.
Crossref
Crossref
Tomasz SkorskiMalgorzata Nieborowska-SkorskaPawel WlodarskiMariusz WasikRossana TrottaPalanisamy KanakarajPaolo SalomoniMark AntonyakRobert MartinezMiroslaw MajewskiAlbert WongBice PerussiaBruno Calabretta. (1998) The SH3 Domain Contributes to BCR/ABL-Dependent Leukemogenesis In Vivo: Role in Adhesion, Invasion, and Homing. Blood 91:2, pages 406-418.
Crossref
Crossref
C. Ponzetto. 1998. Protein Modules in Signal Transduction. Protein Modules in Signal Transduction
165
177
.
B. Clarkson, A. Strife, D. Wisniewski, C. Lambek & N. Carpino. 1998. Acute Leukemias VII. Acute Leukemias VII
146
181
.
Robert C.H. ZhaoR. Scott McIvorJames D. GriffinCatherine M. Verfaillie. (1997) Gene Therapy for Chronic Myelogenous Leukemia (CML): A Retroviral Vector That Renders Hematopoietic Progenitors Methotrexate-Resistant and CML Progenitors Functionally Normal and Nontumorigenic In Vivo. Blood 90:12, pages 4687-4698.
Crossref
Crossref
Robert C.H. ZhaoR. Scott McIvorJames D. GriffinCatherine M. Verfaillie. (1997) Gene Therapy for Chronic Myelogenous Leukemia (CML): A Retroviral Vector That Renders Hematopoietic Progenitors Methotrexate-Resistant and CML Progenitors Functionally Normal and Nontumorigenic In Vivo. Blood 90:12, pages 4687-4698.
Crossref
Crossref
Markus Warmuth, Manuela Bergmann, Andrea Prieß, Kathrin Häuslmann, Bertold Emmerich & Michael Hallek. (1997) The Src Family Kinase Hck Interacts with Bcr-Abl by a Kinase-independent Mechanism and Phosphorylates the Grb2-binding Site of Bcr. Journal of Biological Chemistry 272:52, pages 33260-33270.
Crossref
Crossref
Catherine M. Verfaillie. (1997) STEM CELLS IN CHRONIC MYELOGENOUS LEUKEMIA. Hematology/Oncology Clinics of North America 11:6, pages 1079-1114.
Crossref
Crossref
Arthur B Raitano, Young E Whang & Charles L Sawyers. (1997) Signal transduction by wild-type and leukemogenic Abl proteins. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1333:3, pages F201-F216.
Crossref
Crossref
Kathryn S Kolibaba & Brian J Druker. (1997) Protein tyrosine kinases and cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1333:3, pages F217-F248.
Crossref
Crossref
Carlo Gambacorti-Passerini, Philipp le Coutre, Luca Mologni, Mirco Fanelli, Carla Bertazzoli, Edoardo Marchesi, Massimo Di Nicola, Andrea Biondi, Gian Marco Corneo, Daniela Belotti, Enrico Pogliani & Nicholas B. Lydon. (1997) Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis. Blood Cells, Molecules, and Diseases 23:3, pages 380-394.
Crossref
Crossref
Andrew G. Elefanty, Lorraine Robb & C. Glenn Begley. (1997) 10 Factors involved in leukaemogenesis and haemopoiesis. Baillière's Clinical Haematology 10:3, pages 589-614.
Crossref
Crossref
A.L. PetzerC.J. EavesM.J. BarnettA.C. Eaves. (1997) Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid Leukemia. Blood 90:1, pages 64-69.
Crossref
Crossref
A.L. PetzerC.J. EavesM.J. BarnettA.C. Eaves. (1997) Selective Expansion of Primitive Normal Hematopoietic Cells in Cytokine-Supplemented Cultures of Purified Cells From Patients With Chronic Myeloid Leukemia. Blood 90:1, pages 64-69.
Crossref
Crossref
Arun Bhat, Kathryn Kolibaba, Tsukasa Oda, Sayuri Ohno-Jones, Conor Heaney & Brian J. Druker. (1997) Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed Myeloid Cells. Journal of Biological Chemistry 272:26, pages 16170-16175.
Crossref
Crossref
Charles L. Sawyers. (1997) 3 Signal transduction pathways involved in BCR-ABL transformation. Baillière's Clinical Haematology 10:2, pages 223-231.
Crossref
Crossref
John Groffen & Nora Heisterkamp. (1997) 1 The chimeric BCR-ABL gene. Baillière's Clinical Haematology 10:2, pages 187-201.
Crossref
Crossref
Linda Wolff. (1997) Contribution of oncogenes and tumor suppressor genes to myeloid leukemia. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1332:3, pages F67-F104.
Crossref
Crossref
Ana Maria Tari, Ralph Arlinghaus & Gabriel Lopez-Berestein. (1997) Inhibition of Grb2 and Crkl Proteins Results in Growth Inhibition of Philadelphia Chromosome Positive Leukemic Cells. Biochemical and Biophysical Research Communications 235:2, pages 383-388.
Crossref
Crossref
J A DiGiuseppe & M B Kastan. (1997) Apoptosis in haematological malignancies.. Journal of Clinical Pathology 50:5, pages 361-364.
Crossref
Crossref
Martin Sattler & Ravi Salgia. (1997) Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL. Cytokine & Growth Factor Reviews 8:1, pages 63-79.
Crossref
Crossref
Tetsuzo Tauchi, Keisuke Miyazawa, Gen-Sheng Feng, Hal E. Broxmeyer & Keisuke Toyama. (1997) A Coiled-coil Tetramerization Domain of BCR-ABL Is Essential for the Interactions of SH2-containing Signal Transduction Molecules. Journal of Biological Chemistry 272:2, pages 1389-1394.
Crossref
Crossref
Afshin Samali, Adrienne M. Gorman & Thomas G. Cotter. 1997. Apoptosls - Pharmacological Implications and Therapeutic Opportunities. Apoptosls - Pharmacological Implications and Therapeutic Opportunities
533
552
.
Robin Hesketh. 1997. The Oncogene & Tumour Suppressor Gene Factsbook. The Oncogene & Tumour Suppressor Gene Factsbook
117
123
.
G. D. Telegeev, M. V. Dybkov, M. V. Bozhko, N. M. Tretiak & S. S. Maliuta. (1996) Molecular-biology approaches to detection of Philadelphia chromosome in patients with leukemia. Biopolymers and Cell 12:6, pages 63-68.
Crossref
Crossref
David J. McConkey & Sten Orrenius. (2009) Signal Transduction Pathways in Apoptosis. STEM CELLS 14:6, pages 619-631.
Crossref
Crossref
M. F. Lavin, D. Watters & Q. Song. (1996) Role of protein kinase activity in apoptosis. Experientia 52:10-11, pages 979-994.
Crossref
Crossref
Kristen Senechal, Jocelyn Halpern & Charles L. Sawyers. (1996) The CRKL Adaptor Protein Transforms Fibroblasts and Functions in Transformation by the BCR-ABL Oncogene. Journal of Biological Chemistry 271:38, pages 23255-23261.
Crossref
Crossref
Dean G Tang & Arthur T Porter. (1996) Apoptosis: A current molecular analysis. Pathology & Oncology Research 2:3, pages 117-131.
Crossref
Crossref
Anne M. Gardner & Gary L. Johnson. (1996) Fibroblast Growth Factor-2 Suppression of Tumor Necrosis Factor α-Mediated Apoptosis Requires Ras and the Activation of Mitogen-activated Protein Kinase. Journal of Biological Chemistry 271:24, pages 14560-14566.
Crossref
Crossref
Gary W. Reuther & Ann Marie Pendergast. 1996. Advances in Research and Applications. Advances in Research and Applications
149
175
.
A. M. Tari, N. Neamati, M. Andreeff & G. Lopez-Berestein. 1996. Targeting of Drugs 5. Targeting of Drugs 5
163
168
.